Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4+ T-cell Count?
Authors:
- Gabriela TurkGTGabriela Turk
- Yanina GhiglioneYGYanina Ghiglione
- Macarena HormanstorferMHMacarena Hormanstorfer
- Natalia LauferNLNatalia Laufer
- Romina ColocciniRCRomina Coloccini
- Jimena SalidoJSJimena Salido
- César TrifoneCTCésar Trifone
- María Julia RuizMRMaría Julia Ruiz
- Juliana FaliveneJFJuliana Falivene
- María Pía HolgadoMHMaría Pía Holgado
- María Paula CarusoMCMaría Paula Caruso
- María Inés FigueroaMFMaría Inés Figueroa
Open Access
Abstract
Progression of HIV infection is variable among individuals, and definition disease progression biomarkers is still needed. Here, we aimed to categorize the predictive potential of several variables using feature selection methods and decision trees. A total of seventy-five treatment-naïve subjects were enrolled during acute/early HIV infection. CD4+ T-cell counts (CD4TC) and viral load (VL) levels were determined at enrollment and for one year. Immune activation, HIV-specific immune response, Human Leukocyte Antigen (HLA) and C-C chemokine receptor type 5 (CCR5) genotypes, and plasma levels of 39 cytokines were determined. Data were analyzed by machine learning and non-parametric methods. Variable hierarchization was performed by Weka correlation-based feature selection and J48 decision tree. Plasma interleukin (IL)-10, interferon gamma-induced protein (IP)-10, soluble IL-2 receptor alpha (sIL-2Rα) and tumor necrosis factor alpha (TNF-α) levels correlated directly with baseline VL, whereas IL-2, TNF-α, fibroblast growth factor (FGF)-2 and macrophage inflammatory protein (MIP)-1β correlated directly with CD4+ T-cell activation (p < 0.05). However, none of these cytokines had good predictive values to distinguish “progressors” from “non-progressors”. Similarly, immune activation, HIV-specific immune responses and HLA/CCR5 genotypes had low discrimination power. Baseline CD4TC was the most potent discerning variable with a cut-off of 438 cells/μL (accuracy = 0.93, κ-Cohen = 0.85). Limited discerning power of the other factors might be related to frequency, variability and/or sampling time. Future studies based on decision trees to identify biomarkers of post-treatment control are warrantied.Keywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica and GlaxoSmithKline (PICTO2013/0006)
- Universidad de Buenos Aires (UBACyT 2013-2016, Grant # 20020120200263BA)
- Southwest National Primate Research Center (P51 OD011133)
This publication has 54 references indexed in Scilit:
- Emerging technologies for point-of-care CD4 T-lymphocyte countingTrends in Biotechnology, 2012
- The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of womenAIDS, 2011
- Limited Immunogenicity of HIV CD8+ T-Cell Epitopes in Acute Clade C Virus InfectionThe Journal of Infectious Diseases, 2011
- Plasma cytokine levels during acute HIV-1 infection predict HIV disease progressionAIDS, 2010
- The immune response during acute HIV-1 infection: clues for vaccine developmentNature Reviews Immunology, 2009
- Human Immunodeficiency Virus Type 1-Specific CD8+T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+T CellsJournal of Virology, 2009
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 2009
- Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus InfectionsJournal of Virology, 2009
- Magnitude, Breadth, and Functional Profile of T-Cell Responses during Human Immunodeficiency Virus Primary Infection with B and BF Viral VariantsJournal of Virology, 2008
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006